March 22, 2024

Effectiveness of Topical ρ-Kinase Inhibitors in Veterans with Severe Glaucoma on Maximally Tolerated

Effectiveness of Topical ρ-Kinase Inhibitors in Veterans with Severe Glaucoma on Maximally Tolerated
Effectiveness of Topical ρ-Kinase Inhibitors in Veterans with Severe Glaucoma on Maximally Tolerated
AAOF Clinical Podcast Series
Effectiveness of Topical ρ-Kinase Inhibitors in Veterans with Severe Glaucoma on Maximally Tolerated
Apple Podcasts podcast player icon Apple Podcasts Apple Podcasts Spotify podcast player icon Spotify Spotify
Apple Podcasts podcast player icon Apple Podcasts Apple Podcasts Spotify podcast player icon Spotify Spotify
September 2022 Topical Editor & Hosted by: A. Mika Moy, OD, FAAO Topical Expert: Andrew Mick, OD, FAAO Article: https://pubmed.ncbi.nlm.nih.gov/35848984/